2017   2016   2015   2014   2013   2012   2011   2010   2009   2008  

20. October 2015
Press release: Additional subsidy funding for clinical development of a celiac disease drug
Read more | Document

20. October 2015
Pressemitteilung: Zusätzliche Fördermittel für die klinische Entwicklung eines Zöliakie-Medikamentes
Read more | Document

29. September 2015
New: Recombinant Gliadin Peptides
Read more | Document

22. September 2015
Press Release: Cooperation between Zedira and Cardiff University - Transglutaminase 6 is the focus of new research into ataxia
Read more | Document

18. June 2015
New website launched
Read more | Document

02. March 2015
Press Release: Dr. Falk Pharma and Zedira enter phase I clinical trials for a celiac disease drug
Read more | Document

02. March 2015
Pressemitteilung: Dr. Falk Pharma und Zedira starten klinische Phase I zur medikamentösen Behandlung der Zöliakie
Read more | Document

03. February 2015
Press release: Zedira receives further funding to develop Factor XIIIa-blockers for safe anticoagulation
Read more | Document

  • News  

    • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Blog

  • Events  

    • Transglutaminases in Medicine

      03.08.2017 - 05.08.2017
      Debrecen, Hungary

    • 15th Congress on Amino Acids, Peptides and Proteins

      07.08.2017 - 11.08.2017
      Vienna, Austria

    • 17th International Celiac Disease Symposium

      08.09.2017 - 10.09.2017
      New Delhi, India

    • NLSDays 2017

      12.09.2017 - 14.09.2017
      Malmö, Sweden

    • BIO-Europe

      06.11.2017 - 08.11.2017
      Berlin, Germany

    • MEDICA

      13.11.2017 - 16.11.2017
      Düsseldorf, Germany

    • Gordon Research Conference on: Transglutaminases in Human Disease Processes

      16.06.2018 - 17.06.2018
      Les Diablerets, Switzerland